Skip to content
JACC Specialty Journals cover art

All episodes

JACC Specialty Journals, 1,000 episodes. Page 2 of 10.

#
Title
101

Brief Introduction - SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease | JACC: Asia

102

Brief Introduction - Updated Wilkins Score Predicting Success of Balloon Mitral Valvuloplasty in Rheumatic Mitral Stenosis | JACC: Asia

103

Single Versus Double Perclose Devices for TF-TAVR Access Closure: A Noninferiority Randomized Controlled Trial | JACC: Asia

104

Updated Wilkins Score Predicting Success of Balloon Mitral Valvuloplasty in Rheumatic Mitral Stenosis | JACC: Asia

105

Transcatheter Aortic Valve Replacement in Functionally Dependent Patients: Analysis Using a Government-Adjudicated Long-Term Care Certification | JACC: Asia

106

Brief Introduction - Transcatheter Aortic Valve Replacement in Functionally Dependent Patients: Analysis Using a Government-Adjudicated Long-Term Care Certification | JACC: Asia

107

Novel Allogeneic Mitochondria and Associated Organelle Complex Treatment Prevents Myocardial Ischemia-Reperfusion Injury Through Anti-Apoptotic Effects | JACC: Asia

108

Brief Introduction - Novel Allogeneic Mitochondria and Associated Organelle Complex Treatment Prevents Myocardial Ischemia-Reperfusion Injury Through Anti-Apoptotic Effects | JACC: Asia

109

Brief Introduction - Exercise and Exercise Stress Testing in Brugada Syndrome: Diagnostic, Prognostic, and Safety Implications | JACC: Asia

110

Brief Introduction - Association Between Cardiovascular-Kidney-Metabolic Syndrome and Myocardial Injury After Noncardiac Surgery: A Retrospective Cohort Study | JACC: Asia

111

Brief Introduction - Design of IKISS-LM Randomized Controlled Trial: Impact of Kissing Balloon Inflation on Provisional Left-Main Bifurcation PCI | JACC: Asia

112

Brief Introduction - Myocardial Infarction Without Standard Modifiable Risk Factors From 2025-2040: Forecast Analysis of Multinational, Population-Based Study | JACC: Asia

113

August 2026 Full Issue Summary | JACC: CardioOncology

114

A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral Anticoagulants | JACC: CardioOncology

115

Differential Transthyretin Stabilization in Patients With Wild-Type and Variant Transthyretin Amyloidosis | JACC: CardioOncology

116

Immune Profiling Identifies Inflammatory Signatures in Immune Checkpoint Inhibitor– Related Myocarditis | JACC: CardioOncology

117

Upper Extremity Deep Vein Thrombosis in Cancer Patients: Clinical Course by Cancer Site | JACC: CardioOncology

118

Association Between Clonal Hematopoiesis and Cardiometabolic Disease: A Systematic Review and Meta-Analysis | JACC: CardioOncology

119

Comparison of Flow Ratio Derived From IVUS With CAG in Complex Lesions: Correlation With FFR | JACC Asia

120

Sex Differences in Antiarrhythmic Effects of Empagliflozin: The EMPA-ICD Trial Subanalysis | JACC Asia

121

Association Between Cardiac Acceleration Capacity and Susceptibility to Vasovagal Syncope: Autonomic Dysregulation in Vasovagal Syncope | JACC Asia

122

Cardio-Kidney-Metabolic Phenotypes and Adverse Clinical Outcomes in Patients With Atrial Fibrillation | JACC Asia

123

Postoperative New-Onset Heart Block in Noncardiac Surgery: Model Development, Validation, and Long-Term Prognostic Analysis | JACC Asia

124

The Associations Between Heart Rate, Deformational Echocardiographic Parameters, and Outcomes in Patients With Atrial Fibrillation | JACC Asia

125

Sex Differences in Antiarrhythmic Effects of Empagliflozin: The EMPA-ICD Trial Subanalysis | JACC Asia

126

Development of a Noninvasive Prediction Score for Post-Capillary Pulmonary Hypertension in a Multi-Ethnic Asian Population | JACC Asia

127

Ambrisentan for Early-Stage Low-Risk Pulmonary Arterial Hypertension: Design of the Randomized, Double-Blind, Placebo-Controlled ALEPH Trial | JACC Asia

128

Persistent Atrial Fibrillation With Conduction System Pacing or Pulmonary Vein Isolation: A Prospective Cohort Study | JACC Asia

129

Conceptual Reconsideration of the Classification of Pulmonary Hypertension: From 5 Groups to 2 Groups | JACC Asia

130

Prognostic Value of Murray's Law–Based Quantitative Flow Ratio in Multi-Arterial Coronary Artery Bypass Grafting | JACC Asia

131

Comparison of Clinical Outcomes Between Incomplete and Complete Revascularization in NSTEMI Patients With Multivessel Disease | JACC Asia

132

Comparison of Flow Ratio Derived From IVUS With CAG in Complex Lesions: Correlation With FFR | JACC Asia

133

CRP Cutoff Value in East Asians With Coronary Heart Disease: A Systematic Review and Meta-Analysis | JACC Asia

134

Validation and Recalibration of PCE, China-PAR and PREVENT Models for Estimating ASCVD Risk in China | JACC Asia

135

Accelerometer-Measured Sedentary Behavior, Future Disease, and Cardiovascular-Kidney-Metabolic Health | JACC: Advances

136

Differential Association Between Surrounding Greenness and Mortality in Individuals With Coronary Heart Disease | JACC: Advances

137

Sex Differences in Cardiac Involvement in Adults With Myotonic Dystrophy Type 1: A Multicenter Study | JACC: Advances

138

Characteristics, Management, and Outcomes of Diabetes Subtypes in Patients With Cardiogenic Shock: A Nationwide Analysis | JACC: Advances

139

Comparison of Microcirculation in Chronic Heart Failure, Cardiogenic Shock, LVAD, and Heart Transplantation | JACC: Advances

140

Early Diagnosis of ATTR-CM by Age- and Carpal Tunnel Biopsy-Guided Screening | JACC: Advances

141

Generalizability of Landmark Temporary MCS Device Trials: Insights From the CSWG Registry | JACC: Advances

142

Long-Term Outcomes of Targeted Volume Overload Management in Patients With Severe Aortic Stenosis | JACC: Advances

143

Should Interventionalists Get an MBA? Wayne Batchelor, MD, MHS, MBA Responds | JACC: Cardiovascular Interventions

144

Should Interventionalists Get an MBA? Kirk Garratt, MD, MSc Responds | JACC: Cardiovascular Interventions

145

Should Interventionalists Get an MBA? J. Dawn Abbott, MD Responds | JACC: Cardiovascular Interventions

146

Should Interventionalists Get an MBA? Deepak Bhatt, MD, MPH, MBA Responds | JACC: Cardiovascular Interventions

147

Postoperative New-Onset Heart Block in Noncardiac Surgery: Model Development, Validation, and Long-Term Prognostic Analysis | JACC: Asia

148

Sex-Based Differences in Clinical Outcomes With Edoxaban Therapy: A Prespecified Analysis of the EPIC-CAD Trial | JACC: Asia

149

The Associations Between Heart Rate, Deformational Echocardiographic Parameters and Outcomes in Patients With Atrial Fibrillation | JACC: Asia

150

Cardio-Kidney-Metabolic Phenotypes and Adverse Clinical Outcomes in Patients With Atrial Fibrillation | JACC: Asia

151

Long PR Interval Leads to Atrial Remodeling, Fibrosis and Inducible Atrial Fibrillation in a Swine Model | JACC: Clinical Electrophysiology

152

A Pulsed Field Ablation-Based Endocardial Strategy for Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy | JACC: Clinical Electrophysiology

153

Incidence of Worsening Aortic Regurgitation After Mapping and Ablation in the Aortic Cusps | JACC: Clinical Electrophysiology

154

Associations of Socioeconomic Status With Cardiorenal Metabolic Multimorbidity: Evidence From the UK Biobank Cohort | JACC: Advances

155

Dietary Sodium Intake and Risk of Incident Heart Failure in the Southern Community Cohort Study | JACC: Advances

156

Coronary Sinus Reduction for REDUCER-I Patients With Refractory Angina and Angiographically Nonobstructive Coronary Artery Disease | JACC: Advances

157

Remote Management of Patients With Heart Failure in Medically Underserved Areas | JACC: Advances

158

Development of a Predictive Tool in Patients With High Pretest Probability for Transthyretin Amyloid Cardiomyopathy | JACC: Advances

159

Valvular Heart Diseases in Swedish Males and Females: A National Cohort Study | JACC: Advances

160

Cardiovascular-Kidney-Metabolic Syndrome and Life Expectancy in U.S. Adults | JACC: Advances

161

10-Year Excess Mortality After First-Time Non–ST-Segment Elevation Myocardial Infarction: The Western Denmark Heart Registry | JACC: Advances | JACC: Advances

162

Cardiac Biomarker Complete Response in AL Amyloidosis | JACC: CardioOncology

163

Cardiovascular Adverse Events Associated with Bispecific T-cell Engager Therapy | JACC: CardioOncology

164

Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor–Associated Myocarditis | JACC: CardioOncology

165

June 2026 Issue Summary | JACC: CardioOncology

166

Stepwise Assessment of Computational Coronary Physiology and Plaque Vulnerability: Impact on Coronary Revascularization Decision Making | JACC: Asia

167

The Future of Cardio-Oncology: Progress and Priorities | ACC.26 | JACC: CardioOncology

168

Cardiogenic Shock From ICI Myocarditis With Predominant RV Failure | ACC.26 | JACC: CardioOncology

169

Risk Scores for Transcatheter Tricuspid Interventions | JACC: Cardiovascular Interventions

170

Frequency and Outcomes of Acute Hemodynamic Instability Following TTVR | JACC: Cardiovascular Interventions

171

His-Pacing versus Biventricular Pacing for Cardiac Resynchronization Therapy: Long-term follow-up from the His-alternative I Trial | JACC: Clinical Electrophysiology

172

Return-to-Play for Athletes with Desmosomal Arrhythmogenic Cardiomyopathy: A Single Center Experience | JACC: Clinical Electrophysiology

173

Functional Conduction Block During Extra-Stimulus Mapping Masks Deceleration Zones and Reveals Additional VT Substrate | JACC: Clinical Electrophysiology

174

LONG-TERM OUTCOMES AND SAFETY OF HIS-PURKINJE CONDUCTION SYSTEM PACING: A MULTICENTER OBSERVATIONAL STUDY IN CHINA (The ChiCSP Study)

175

His Pacing vs Biventricular Pacing for Cardiac Resynchronization Therapy | JACC: Clinical Electrophysiology

176

April 2026 Issue Summary | JACC: Asia

177

Profiles of Comprehensive Morphological Phenotypes and Outcomes in Functional Mitral Regurgitation | JACC: Asia

178

The Effect of High-Density Lipoprotein on the Rheumatic Mitral Valve Calcification and Surgical Prognosis | JACC: Asia

179

Biological Age Acceleration and All-Cause Mortality in Moderate to Severe Aortic Valve Stenosis: A Prospective Cohort Study | JACC: Asia

180

Early Safety and Feasibility Study of a Novel Transcatheter Aortic Valve With Polymeric Leaflets | JACC: Asia

181

Early Safety and Feasibility Study of a Novel Transcatheter Aortic Valve With Polymeric Leaflets | JACC: Asia

182

Effect of Device Size on Outcomes Following Left Atrial Appendage Closure in Borderline-Sized Anatomy | JACC: Asia

183

Prognostic Value of Left Ventricular Kinetic Energy for Predicting Major Adverse Events in Hypertrophic Cardiomyopathy | JACC: Asia

184

Prognostic Value of Left Ventricular Kinetic Energy for Predicting Major Adverse Events in Hypertrophic Cardiomyopathy | JACC: Asia

185

Cardiometabolic Risk Among Internal Medicine Specialists in Indonesia (CARMEINA): A Nationwide Study | JACC: Asia

186

Left Atrial Strain Outperforms Ventricular Strains in Cardiovascular Outcome Association Across Echocardiography and Magnetic Resonance | JACC: Asia

187

Temporal Trends in Age Profile and Safety of Balloon Pulmonary Angioplasty for CTEPH | JACC: Asia

188

Importance and Management of Non-High-Density Lipoprotein Cholesterol in Dyslipidemia Treatment | JACC: Asia

189

Use of Electrocardiograms to Identify Coronary Artery Disease: Cross-Validation of an Artificial Intelligence Model | JACC: Advances

190

VExUS Point-of-Care Ultrasound Tool to Detect Changes in Volume Status: A Prospective Observational Study | JACC: Advances

191

Comparative Strategies to Overcome Diuretic Resistance in Heart Failure: A Network Meta-Analysis | JACC: Advances

192

Prehabilitation in Patients Undergoing Cardiac Procedures: A Systematic Review and Meta-Analysis | JACC: Advances

193

Pregnancy in Women With Impaired Left Ventricular Function: Data From ROPAC | JACC: Advances

194

Cardiac Rehabilitation Utilization Among Veterans: A Sex-Based Analysis | JACC: Advances

195

Frailty Status Predicts Adverse Outcomes in Ambulatory Heart Failure With Preserved Ejection Fraction | JACC: Advances

196

Intracoronary Vasoactive Therapy for No-Reflow During Primary PCI: A Network Meta-Analysis of Randomized Trials | JACC: Advances

197

Mechanical Debulking in Calcified Arteries: ROLLING STONE Study | JACC: Cardiovascular Interventions

198

TRANScatheter edge-to-edge rePAir for SAM related mitral REgurgitation in patieNTs with HCM. The TRANSPARENT registry | JACC: Cardiovascular Interventions

199

Comparing High-Density Electroanatomical Mapping and MRI: a step forward in myocardial characterization in non-ischemic cardiomyopathy

200

Predictors of Bleeding Complications After Extracorporeal Cardiopulmonary Resuscitation: Insights From the SAVE-J II Study | JACC: Asia